Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Lipid Mediators, M2 Macrophages, and Pathological Neovascularization.

Swendeman SL, Hla T.

Trends Mol Med. 2018 Dec;24(12):977-978. doi: 10.1016/j.molmed.2018.10.003. Epub 2018 Nov 15.

PMID:
30448396
2.

An engineered S1P chaperone attenuates hypertension and ischemic injury.

Swendeman SL, Xiong Y, Cantalupo A, Yuan H, Burg N, Hisano Y, Cartier A, Liu CH, Engelbrecht E, Blaho V, Zhang Y, Yanagida K, Galvani S, Obinata H, Salmon JE, Sanchez T, Di Lorenzo A, Hla T.

Sci Signal. 2017 Aug 15;10(492). pii: eaal2722. doi: 10.1126/scisignal.aal2722.

3.

HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver.

Ding BS, Liu CH, Sun Y, Chen Y, Swendeman SL, Jung B, Chavez D, Cao Z, Christoffersen C, Nielsen LB, Schwab SR, Rafii S, Hla T.

JCI Insight. 2016 Dec 22;1(21):e87058. doi: 10.1172/jci.insight.87058.

4.

Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate receptor 1.

Christensen PM, Liu CH, Swendeman SL, Obinata H, Qvortrup K, Nielsen LB, Hla T, Di Lorenzo A, Christoffersen C.

FASEB J. 2016 Jun;30(6):2351-9. doi: 10.1096/fj.201500064. Epub 2016 Mar 8.

5.

HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation.

Galvani S, Sanson M, Blaho VA, Swendeman SL, Obinata H, Conger H, Dahlb├Ąck B, Kono M, Proia RL, Smith JD, Hla T.

Sci Signal. 2015 Aug 11;8(389):ra79. doi: 10.1126/scisignal.aaa2581. Erratum in: Sci Signal. 2015 Oct 27;8(400):er8. Obinata, Hideru [added].

6.

HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation.

Blaho VA, Galvani S, Engelbrecht E, Liu C, Swendeman SL, Kono M, Proia RL, Steinman L, Han MH, Hla T.

Nature. 2015 Jul 16;523(7560):342-6. doi: 10.1038/nature14462. Epub 2015 Jun 8.

7.

iRHOM2 is a critical pathogenic mediator of inflammatory arthritis.

Issuree PD, Maretzky T, McIlwain DR, Monette S, Qing X, Lang PA, Swendeman SL, Park-Min KH, Binder N, Kalliolias GD, Yarilina A, Horiuchi K, Ivashkiv LB, Mak TW, Salmon JE, Blobel CP.

J Clin Invest. 2013 Feb;123(2):928-32. doi: 10.1172/JCI66168. Epub 2013 Jan 25.

8.

Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17.

Maretzky T, Evers A, Zhou W, Swendeman SL, Wong PM, Rafii S, Reiss K, Blobel CP.

Nat Commun. 2011;2:229. doi: 10.1038/ncomms1232.

9.

A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival.

Pearse RN, Swendeman SL, Li Y, Rafii D, Hempstead BL.

Blood. 2005 Jun 1;105(11):4429-36. Epub 2005 Jan 18.

10.

Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro.

Coffey DC, Kutko MC, Glick RD, Swendeman SL, Butler L, Rifkind R, Marks PA, Richon VM, LaQuaglia MP.

Med Pediatr Oncol. 2000 Dec;35(6):577-81.

PMID:
11107121
11.

Identification and characterization of a critical CP2-binding element in the human interleukin-4 promoter.

Casolaro V, Keane-Myers AM, Swendeman SL, Steindler C, Zhong F, Sheffery M, Georas SN, Ono SJ.

J Biol Chem. 2000 Nov 24;275(47):36605-11.

12.

The effects of serum depletion and dexamethasone on growth and differentiation of human neuroblastoma cell lines.

Glick RD, Medary I, Aronson DC, Scotto KW, Swendeman SL, La Quaglia MP.

J Pediatr Surg. 2000 Mar;35(3):465-72.

PMID:
10726691
13.

Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma.

Glick RD, Swendeman SL, Coffey DC, Rifkind RA, Marks PA, Richon VM, La Quaglia MP.

Cancer Res. 1999 Sep 1;59(17):4392-9.

14.

cDNA subtraction hybridization: a review and an application to neuroblastoma.

Swendeman SL, La Quaglia MP.

Semin Pediatr Surg. 1996 Aug;5(3):149-54. Review.

PMID:
8858760
16.

Characterization of the genomic structure, chromosomal location, promoter, and development expression of the alpha-globin transcription factor CP2.

Swendeman SL, Spielholz C, Jenkins NA, Gilbert DJ, Copeland NG, Sheffery M.

J Biol Chem. 1994 Apr 15;269(15):11663-71.

17.

Characterization of the molecularly cloned murine alpha-globin transcription factor CP2.

Lim LC, Fang L, Swendeman SL, Sheffery M.

J Biol Chem. 1993 Aug 25;268(24):18008-17.

18.

Molecular cloning of the alpha-globin transcription factor CP2.

Lim LC, Swendeman SL, Sheffery M.

Mol Cell Biol. 1992 Feb;12(2):828-35.

19.

Promoter elements and erythroid cell nuclear factors that regulate alpha-globin gene transcription in vitro.

Kim CG, Swendeman SL, Barnhart KM, Sheffery M.

Mol Cell Biol. 1990 Nov;10(11):5958-66.

20.

Soluble CD23/BLAST-2 (S-CD23/Blast-2) and its role in B cell proliferation.

Swendeman SL, Thorley-Lawson D.

Curr Top Microbiol Immunol. 1988;141:157-64. No abstract available.

PMID:
2975205
21.

Biochemical analysis suggests distinct functional roles for the BLAST-1 and BLAST-2 antigens.

Thorley-Lawson DA, Swendeman SL, Edson CM.

J Immunol. 1986 Mar 1;136(5):1745-51.

PMID:
3081632

Supplemental Content

Loading ...
Support Center